Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by heparin

AUTOR(ES)

Straub, P. W.

RESUMO

In a patient with generalized prostatic carcinoma and hypofibrinogenaemia heparin infusion on four occasions abolished systemic fibrinolysis as determined by euglobulin clot lysis time, bovine fibrin plate assay, thromboelastography, and immunoelectrophoretic demonstration of fibrinogen split products.

Documentos Relacionados

• Fibrinolysis and carcinoma of the prostate
• Imaging metastatic bone disease from carcinoma of the prostate
• Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma
• Thoracic cord compression from metastatic prostate carcinoma with Lhermitte's "sign".
• Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.